Page last updated: 2024-09-02

oxymatrine and Psoriasis

oxymatrine has been researched along with Psoriasis in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Groma, G1
Huang, X; Li, Q; Mei, Z; Tu, C; Wang, W; Xiang, X; Xiong, H; Zhao, Z1
Chen, Q; Chi, M; Deng, X; Leavesley, D; Shi, H; Xie, N; Xie, Y; Yang, Y; Zhang, H; Zhou, H1
Bo, KP; Gao, Q; Ma, AL; Ma, W; Shi, HJ; Song, HB; Wang, L; Zhang, N; Zhou, H1
Bo, KP; Chen, WG; Ma, W; Shi, HJ; Song, HB; Xia, L; Yang, J; Zhou, H1

Trials

2 trial(s) available for oxymatrine and Psoriasis

ArticleYear
Oxymatrine therapy inhibited epidermal cell proliferation and apoptosis in severe plaque psoriasis.
    The British journal of dermatology, 2019, Volume: 181, Issue:5

    Topics: Acitretin; Adult; Alkaloids; Apoptosis; Biopsy; Cell Proliferation; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Keratinocytes; Male; Psoriasis; Quinolizines; Severity of Illness Index; Skin; Treatment Outcome; Young Adult

2019
Efficacy of oxymatrine for treatment and relapse suppression of severe plaque psoriasis: results from a single-blinded randomized controlled clinical trial.
    The British journal of dermatology, 2017, Volume: 176, Issue:6

    Topics: Acitretin; Adult; Alkaloids; Drug Administration Schedule; Female; Humans; Injections, Intravenous; Keratolytic Agents; Male; Psoriasis; Quality of Life; Quinolizines; Secondary Prevention; Single-Blind Method; Treatment Outcome

2017

Other Studies

3 other study(ies) available for oxymatrine and Psoriasis

ArticleYear
Oxymatrine may represent an additional therapeutic tool in severe plaque psoriasis management.
    The British journal of dermatology, 2019, Volume: 181, Issue:5

    Topics: Alkaloids; Apoptosis; Cell Proliferation; Humans; Psoriasis; Quinolizines

2019
Oxymatrine ameliorates imiquimod-induced psoriasis pruritus and inflammation through inhibiting heat shock protein 90 and heat shock protein 60 expression in keratinocytes.
    Toxicology and applied pharmacology, 2020, 10-15, Volume: 405

    Topics: Alkaloids; Animals; Anti-Inflammatory Agents; Chaperonin 60; Disease Models, Animal; Down-Regulation; HaCaT Cells; HSP90 Heat-Shock Proteins; Humans; Imiquimod; Keratinocytes; Male; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; Protein Binding; Pruritus; Psoriasis; Quinolizines

2020
Investigating the potential of Oxymatrine as a psoriasis therapy.
    Chemico-biological interactions, 2017, Jun-01, Volume: 271

    Topics: Adolescent; Adult; Aged; Alkaloids; Anti-Inflammatory Agents, Non-Steroidal; Cell Proliferation; Cells, Cultured; Female; Gene Expression Regulation; Humans; Keratinocytes; Male; Membrane Proteins; Middle Aged; Models, Biological; Psoriasis; Quinolizines; Retrospective Studies; Skin

2017